Loading compound...
Small molecule inhibitor
Alvelestat is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat various respiratory conditions like cystic fibrosis, COPD, and bronchiectasis, as well as for use in COVID-19 and certain blood cancers.
How it worksAlvelestat is a small molecule designed to target specific biological pathways, though the exact way it works in the body is still being studied in clinical research.
Used for
Cystic fibrosisChronic obstructive pulmonary disease (COPD)BronchiectasisHematopoietic and lymphoid cell neoplasms (blood cancers)COVID-19
Conditions
Cystic fibrosisChronic obstructive pulmonary diseaseBronchiectasisHematopoietic and lymphoid cell neoplasmCOVID-19
Class
Small moleculeSmall molecule inhibitorRespiratory systemHematologic system
How to take
Specific dosing instructions are not yet available as the drug is in clinical development phases.
Talk to your doctor
Questions to ask
- ·What stage of clinical trials is Alvelestat currently in?
- ·How might Alvelestat affect my specific respiratory condition?
- ·Are there any known risks for Alvelestat in its current research phase?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
